Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
暂无分享,去创建一个
T. Koike | T. Atsumi | M. Mukai | T. Nakabayashi | M. Ieko | S. Naito | Mika Yoshida | K. Kanazawa | Kazuhiro Mizukami